Geulah Livshits

Geulah Livshits

#1566 out of 1697 analysts
Chardan Capital
Automatically Tracked
Tracking: 0 Updated: Jul 29 at 06:38 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-36.63%
Gain -5.88%
Monthly
0.12%
Yearly
1.42%
Drawdown
87.74%
$108,502.73
Equity
Holdings
$108,502.67
Cash
$0.07
Investment
$119,521.23
$8,502.73
Profit -$6,788.16
Realized
$19,521.29
Unrealized
-$11,018.56
Dividends
$0
$0.07
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-5.88%
Profit
-$6,788.16
Win %
30%
This Week
Compared To Last Week
Gain
-6.7%
Profit
-$7,785.58
Win %
30%
This Month
Compared to last month
Gain
-15.41%
Profit
-$19,764.66
Win %
30%
This Year
Compared to last year
Gain
2.4%
Profit
$2,546.06
Win %
62%
Intellia Therapeutics Inc. logo
NTLA Intellia Therapeutics Inc.
+2.06%
+$165.97
Immatics N.V. logo
IMTX Immatics N.V.
+1.22%
+$138.78
Pavella Therapeutics Inc. logo
PVLA Pavella Therapeutics Inc.
+0.76%
+$90.84
Iovance Biotherapeutics, Inc. logo
IOVA Iovance Biotherapeutics, Inc.
-4.08%
-$592.15
Climb Biotherapeutics, Inc. logo
CLYM Climb Biotherapeutics, Inc.
-3.91%
-$481.01
Rocket Pharmaceuticals Inc. logo
RCKT Rocket Pharmaceuticals Inc.
-3.38%
-$425.89
Immuneering Corporation logo
IMRX Immuneering Corporation
-2.75%
-$317.22
Editas Medicine Inc. logo
EDIT Editas Medicine Inc.
-2.24%
-$264.91
Lexeo Therapeutics Inc. logo
LXEO Lexeo Therapeutics Inc.
-1.79%
-$211.93
Senti Biosciences Inc. logo
SNTI Senti Biosciences Inc.
-0.11%
-$4.62
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
2018
Longs Won
833/2018 41%
Profit Factor
1.01
Profitability
Shorts Won
0/0 0%
Standard Deviation
$1,724.49
Average Win
$694.35
Best Trade
(Feb 20) $21,358.54
Sharpe Ratio
-222.67
Average Loss
-$480.92
Worst Trade
(Feb 25) -$17,096.67
Z-Score
-12.3 (100%)
Commissions
$0
Avg. Trade Length
2m 3w 3d
Expectancy
$4.21
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% 49.4% 61.08% 69.16% 75.53% 80.87% 85.52% 89.65% 93.39% 96.82%
Consecutive Losing Trades 226 203 181 158 135 113 90 68 45 23
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV